Musings
Meso kept producing Rem-l and we have circa 1000 doses.
Company updates stated getting ready for commercial approval of Ryoncil.
Annual doses required in year one was, from memory, only 300 or so doses.
So is the stock build really for the confirmatory Ards trial ?
Say 300 at under 65’s with Dex
100 exploratory under 65’s earlier dose.
100 exploratory over 65’s allowing for up to three doses.
Look at me being a scientist
I have no idea - just a question around the stock build up approved by the board without a license to market
Reg
MSB Trading 2021 - paradigm shift, page-9538
-
- There are more pages in this discussion • 673 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.45 |
Change
0.065(4.69%) |
Mkt cap ! $1.655B | |||
| Open | High | Low | Value | Volume |
| $1.39 | $1.50 | $1.38 | $7.016M | 4.856M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10425 | $1.44 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.45 | 44243 | 5 |
View Market Depth
| Last trade - 16.10pm 11/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |